Automated Production of Viral Vectors for Cell and Gene Therapy with Genedata Biologics

Genedata Biopharma Partner Symposium, Basel, Switzerland
March 6, 2024

The efficient production of high-quality viral vectors such as recombinant adeno-associated virus (rAAV) and lentivirus represents a key step in any cell and gene therapy (CGT) discovery workflow.

Here, we demonstrate how the Genedata Biologics^® platform can be used for the registration of virus vectors as well as the monitoring, controlling and evaluation of all production processes performed in the laboratory. The streamlined data management of such highly complex, automated and high-throughput processes is key for process optimization and accelerated identification of therapeutic CGT candidates.